Favorable Response to mTOR Inhibition in a Young Patient With Unresectable Fibrolamellar Carcinoma of the Liver

Hepatology - United States
doi 10.1002/hep.29853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

DNAJB1–PRKACAfusion Kinase Interacts With Β-Catenin and the Liver Regenerative Response to Drive Fibrolamellar Hepatocellular Carcinoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Complete Response to Chemotherapy in a Patient With Unresectable Extrahepatic Cholangiocarcinoma

Archives of Clinical and Medical Case Reports
2019English

Fibrolamellar Carcinoma of the Liver in a Middle-Aged Korean Man

Journal of UOEH
MedicineEnvironmentalPublic HealthOccupational Health
1990English

Liver Transplantation After Radioembolization in a Patient With Unresectable HCC

Nature Reviews Gastroenterology and Hepatology
HepatologyGastroenterology
2009English

Favorable Response to Chemotherapy in a Patient of Urachal Adenocarcinoma With Peritoneal Metastasis

Kansas Journal of Medicine
2015English

Liver Transplantation for Fibrolamellar Hepatocellular Carcinoma: Analysis of the UNOS Database

HPB
HepatologyGastroenterology
2016English

Fibrolamellar Carcinoma: A Concise Review

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2018English

A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient With Fibrolamellar Hepatocellular Carcinoma Without Ornithine Transcarbamylase (OTC) Mutation

American Journal of Case Reports
Medicine
2017English

Sorafenib Continuation or Discontinuation in Patients With Unresectable Hepatocellular Carcinoma After a Complete Response

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy